chloral hydrate has been researched along with Bronchopulmonary Dysplasia in 2 studies
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartley, S | 1 |
| Franck, LS | 1 |
| Lundergan, F | 1 |
| Gonzalez, JL | 1 |
| Lambert, GH | 1 |
| Muraskas, J | 1 |
| Anderson, CL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pharmacotoxicology of Trichloroethylene Metabolites: Short-term Effect of DCA on in Vivo Tyrosine Catabolism and MAAI Expression[NCT00865514] | 2 participants (Actual) | Interventional | 2011-08-31 | Terminated (stopped due to Difficulty in obtaining the solution from the compounding pharmacies caused a two year delay in start-up; the funding ended prior to study completion.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for chloral hydrate and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Maintenance sedation of agitated infants in the neonatal intensive care unit with chloral hydrate: new concerns.
Topics: Bronchopulmonary Dysplasia; Chloral Hydrate; Humans; Infant; Infant, Newborn; Intensive Care Units, | 1989 |
Hypertriglyceridemia in infants with bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Chloral Hydrate; Humans; Hypertriglyceridemia; Infant, Newborn | 1989 |